Differential regulatory T cell activity in hiv type 1-exposed seronegative individuals

AIDS Research and Human Retroviruses

Volumn 29, Issue 10, 2013, Pages 1321-1329

  Pattacini, Laura ^a   Murnane, Pamela M ^b   Kahle, Erin M ^b,c   Bolton, Michael J ^a   Delrow, Jeffrey J ^a   Lingappa, Jairam R ^b,d   Katabira, Elly ^c   Donnell, Deborah ^b   McElrath, M Juliana ^a,b   Baeten, Jared M ^b   Lund, Jennifer M ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SERODIAGNOSIS;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHEMOKINE CCL4; FEMALE; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84885143519     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0075     Document Type: Article

References (53)

1. Horton RE, McLaren PJ, Fowke K, Kimani J, and Ball TB: Cohorts for the study of HIV-1-exposed but uninfected individuals: Benefits and limitations. J Infect Dis 2010;202(Suppl 3): S377-381.
2. Dunkle KL, Stephenson R, Karita E, et al.: New heterosexually transmitted HIV infections in married or cohabitating couples in urban Zambia and Rwanda: An analysis of survey and clinical data. Lancet 2008;371:2183-2191. (Pubitemid 351885039)
3. Kaul R, Rowland-Jones SL, Kimani J, et al.: Late seroconversion in HIV-resistant Nairobi prostitutes despite preexisting HIV-specific CD8 + responses. J Clin Invest 2001; 107(3):341-349. (Pubitemid 32157966)
4. Clerici M, Levin JM, Kessler HA, et al.: HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 1994;271(1):42-46. (Pubitemid 24020578)
5. Rowland-Jones SL, Nixon DF, Aldhous MC, et al.: HIVspecific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 1993;341(8849):860-861. (Pubitemid 23094512)
6. Quillent C, Oberlin E, Braun J, et al.: HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 1998;351(9095):14-18. (Pubitemid 28020160)
7. Ranki A, Mattinen S, Yarchoan R, et al.: T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners. AIDS 1989;3(2):63-69. (Pubitemid 19073453)
8. Piacentini L, Fenizia C, Naddeo V, and Clerici M: Not just sheer luck! Immune correlates of protection against HIV-1 infection. Vaccine 2008;26(24):3002-3007.
9. Miyazawa M, Lopalco L, Mazzotta F, Lo Caputo S, Veas F, and Clerici M: The 'immunologic advantage' of HIVexposed seronegative individuals. AIDS 2009;23(2):161-175.
10. Lo Caputo S, Trabattoni D, Vichi F, et al.: Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men. AIDS 2003;17(4):531-539. (Pubitemid 36293106)
11. Tran HK, Chartier L, Troung LX, et al.: Systemic immune activation in HIV-1-exposed uninfected Vietnamese intravascular drug users. AIDS Res Hum Retroviruses 2006;22(3): 255-261.
12. Schenal M, Lo Caputo S, Fasano F, et al.: Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients. AIDS 2005; 19(7):653-661. (Pubitemid 40593070)
13. Pallikkuth S, Wanchu A, Bhatnagar A, Sachdeva RK, and Sharma M: Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India. Clin Vaccine Immunol 2007;14(9):1196-1202. (Pubitemid 47518087)
14. Migueles SA, Laborico AC, Shupert WL, et al.: HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3(11):1061-1068. (Pubitemid 35363659)
15. Buseyne F, Scott-Algara D, Porrot F, et al.: Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon- producing CD8 + T cells in infected children correlate positively with plasma viral load. J Virol 2002;76(24):12414-12422. (Pubitemid 35386927)
16. Scheibenbogen C, Romero P, Rivoltini L, et al.: Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: A four-centre comparative trial. J Immunol Methods 2000; 244(1-2):81-89.
17. Lajoie J, Juno J, Burgener A, et al.: A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunol 2012;5(3):277-287.
18. Suresh P, Wanchu A, Bhatnagar A, Sachdeva RK, and Sharma M: Spontaneous and antigen-induced chemokine production in exposed but uninfected partners of HIV type 1-infected individuals in North India. AIDS Res Hum Retroviruses 2007;23(2):261-268. (Pubitemid 46418339)
19. Casazza JP, Brenchley JM, Hill BJ, et al.: Autocrine production of beta-chemokines protects CMV-specific CD4 T cells from HIV infection. PLoS Pathog 2009;5(10):e1000646.
20. Card CM, McLaren PJ, Wachihi C, Kimani J, Plummer FA, and Fowke KR: Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4 (+) CD25 (+) FOXP3 (+) regulatory T cells. J Infect Dis 2009;199(9):1318-1322.
21. McLaren PJ, Ball TB, Wachihi C, et al.: HIV-exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+ T cell compartment and reduced expression of HIV-dependent host factors. J Infect Dis 2010; 202(Suppl 3):S339-344.
22. Songok EM, Luo M, Liang B, et al.: Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state. PLoS One 2012;7(1):e30048.
23. Campbell DJ and Koch MA: Phenotypical and functional specialization of FOXP3 + regulatory T cells. Nat Rev Immunol 2010;11(2):119-130.
24. Lund JM, Hsing L, Pham TT, and Rudensky AY: Coordination of early protective immunity to viral infection by regulatory T cells. Science 2008;320(5880):1220-1224. (Pubitemid 351929511)
25. Angin M, King M, Altfeld M, Walker BD, Wucherpfennig KW, and Addo MM: Identification of HIV-1-specific regulatory T-cells using HLA class II tetramers. AIDS 2012; 26(16):2112-2115.
26. Legrand FA, Nixon DF, Loo CP, et al.: Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS One 2006;1:e102.
27. Li F, Malhotra U, Gilbert PB, et al.: Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation. Vaccine 2006;24(47-48):6893-6904. (Pubitemid 46107181)
28. Defawe OD, Fong Y, Vasilyeva E, et al.: Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells. J Immunol Methods 2012;382:117-128.
29. Venken K, Thewissen M, Hellings N, et al.: A CFSE based assay for measuring CD4+ CD25 + regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J Immunol Methods 2007;322(1-2):1-11. (Pubitemid 46560587)
30. Du P, Kibbe WA, and Lin SM: lumi: A pipeline for processing Illumina microarray. Bioinformatics 2008;24(13):1547-1548. (Pubitemid 351911712)
31. Smyth GK: Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Springer, New York, 2005.
32. Reiner A, Yekutieli D, and Benjamini Y: Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003;19(3):368-375. (Pubitemid 36284936)
33. Tusher VG, Tibshirani R, and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98(9):5116-5121. (Pubitemid 32397092)
34. Tomescu C, Abdulhaqq S, and Montaner LJ: Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). Clin Exp Immunol 2011; 164(2):158-169.
35. Capobianchi MR, Abbate I, Antonelli G, Turriziani O, Dolei A, and Dianzani F: Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages. AIDS Res Hum Retroviruses 1998;14(3):233-240. (Pubitemid 28084017)
36. Wasik TJ, Bratosiewicz J, Wierzbicki A, et al.: Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol 1999;162(7):4355-4364. (Pubitemid 29314829)
37. Alimonti JB, Kimani J, Matu L, et al.: Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya. Immunol Cell Biol 2006;84(5):482-485. (Pubitemid 44286043)
38. Alimonti JB, Koesters SA, Kimani J, et al.: CD4+ T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women. J Infect Dis 2005;191(1):20-24. (Pubitemid 40041395)
39. Jennes W, Vuylsteke B, Borget MY, et al.: HIV-specific T helper responses and frequency of exposure among HIVexposed seronegative female sex workers in Abidjan, Cote d'Ivoire. J Infect Dis 2004;189(4):602-610. (Pubitemid 38270912)
40. Sriwanthana B, Hodge T, Mastro TD, et al.: HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand. AIDS Res Hum Retroviruses 2001; 17(8):719-734. (Pubitemid 32692410)
41. Perez CL, Hasselrot K, Bratt G, Broliden K, and Karlsson AC: Induction of systemic HIV-1-specific cellular immune responses by oral exposure in the uninfected partner of discordant couples. AIDS 2010;24(7):969-974.
42. Beretta A, Furci L, Burastero S, et al.: HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection. Immunol Lett 1996;51(1-2):39-43. (Pubitemid 26227469)
43. Murashev BV, Nazarenko OV, Akulova EB, et al.: The high frequency of HIV type 1-specific cellular immune responses in seronegative individuals with parenteral and/or heterosexual HIV type 1 exposure. AIDS Res Hum Retroviruses 2012;28(12):1598-1605.
44. Wawer MJ, Gray RH, Sewankambo NK, et al.: Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005;191(9):1403-1409. (Pubitemid 40563350)
45. Restrepo C, Rallon NI, del Romero J, et al.: Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals. J Immunol 2010;185(2):982-989.
46. Goh WC, Markee J, Akridge RE, et al.: Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: Evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. J Infect Dis 1999;179(3):548-557. (Pubitemid 30016137)
47. Addo MM, Altfeld M, Brainard DM, et al.: Lack of detectable HIV-1-specific CD8 (+) T cell responses in Zambian HIV-1-exposed seronegative partners of HIV-1-positive individuals. J Infect Dis 2011;203(2):258-262.
48. Sharma MD, Hou DY, Baban B, et al.: Reprogrammed foxp3 (+) regulatory T cells provide essential help to support cross-presentation and CD8 (+) T cell priming in naive mice. Immunity 2010;33(6):942-954.
49. Yang XO, Nurieva R, Martinez GJ, et al.: Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008;29(1):44-56.
50. Addo MM, Altfeld M, Brainard DM, et al.: Lack of detectable HIV-1-specific CD8 (+) T cell responses in Zambian HIV-1-exposed seronegative partners of HIV-1-positive individuals. J Infect Dis 2011;203(2):258-262.
51. Shaw JM, Hunt PW, Critchfield JW, et al.: Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. J Virol 2011;85(21):11422-11434.
52. Weiss L, Piketty C, Assoumou L, et al.: Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy. PLoS One 2010;5(7):e11659.
53. Mackelprang RD, Baeten JM, Donnell D, et al.: Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1. J Infect Dis 2012;206(8):1299-1308.